daclizumab subcutaneous

drug_tag_22526
Back
No image

Description

Daclizumab injection, which is sold under the brand name “Zinbryta”, is used to treat “the relapsing forms of multiple sclerosis (MS)”. Even though this drug will not cure MS per se, it may nonetheless decrease the number of MS flares and lesions. According to medicinenet.com, Daclizumab “may work by modifying immune processes that may be responsible for causing MS by interfering with the activation of lymphocytes (a type of white blood cell) that cause inflammation and destruction of nerves in patients with MS.” Before using Daclizumab, you should tell your doctor if you’ve ever been allergic to any drug, or if you have other types of allergies. Also don’t forget to consult them if you are pregnant or breastfeeding before taking the medicine in question. Bear in mind that certain health conditions may make Daclizumab less effective, or even unsafe. Therefore, you must tell your doctor before using this drug if you have other medical problems such as liver disease, depression, or a weak immune system. As far as the common side effects are concerned, they include body aches, sadness, headache, fever, and bloody urine. You should, of course, check with your doctor if any of the aforementioned side effects occurs. According to drugs.com, Daclizumab may also cause serious allergic reactions that can be life-threatening, including anaphylaxis and angioedema. If you experience any of these allergic reactions, seeking immediate medical care is highly recommended.
Full size image
0
Subcategories
0
Active
0
Languages
Control Plane

Visual Identity

Source: generated
Icon fas fa-box
Gradient linear-gradient(135deg, #64748b, #475569)
Icon Source generated

Control Plane

No control plane mapping. This entity is not linked to a capability group.

All Languages (0)

Both name + description
Only one
Not translated
Double-click name or description to edit
Language Status Name Translation Description Translation AI Checked Translator Last Updated History

Translation History

Loading history...

Configuration

No configuration attributes set.

Move: daclizumab subcutaneous

(root — no parent)